The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma.
Wu L, Gao Y, Xie S, Ye W, Uemura Y, Zhang R, Yu Y, Li J, Chen M, Wu Q, Cui P, Liu H, Mu S, Li Y, Wang L, Liu C, Li J, Zhang L, Jiao S, Zhang G, Liu T.
Wu L, et al. Among authors: liu h, liu c, liu t.
Transl Oncol. 2023 Nov;37:101775. doi: 10.1016/j.tranon.2023.101775. Epub 2023 Sep 6.
Transl Oncol. 2023.
PMID: 37678132
Free PMC article.